Research from liquid biopsy company Angle and genetic sequencing giant Illumina reveals that analyzing whole tumor cells, rather than solely DNA fragments, could provide a more comprehensive picture of cancer genetics.
“We found active, clinically relevant mutations in the intact living cells which are not present in the dead DNA fragments,”...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?